Skip to main content
Clinical Trials/ACTRN12620001142921
ACTRN12620001142921
Completed
未知

The influence of whole-body cryotherapy on hemorheological parameters, indicators of oxidative stress, level of interleukin 6 and matrix metallopeptidase 9 and level of Vitamin D in women with multiple sclerosis and healthy controls.

Bartlomiej Ptaszek0 sites45 target enrollmentNovember 2, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Bartlomiej Ptaszek
Enrollment
45
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 2, 2020
End Date
September 5, 2019
Last Updated
5 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Bartlomiej Ptaszek

Eligibility Criteria

Inclusion Criteria

  • diagnosis: multiple sclerosis \- ICD10: G35 (confirmed by imaging: magnetic resonance imaging, cerebrospinal fluid examination, examination of visual evoked potentials)
  • age: 30 \- 55 years old
  • Expanded Disability Status Scale \- value from 0 to 6
  • no contraindications to whole body cryotherapy
  • written consent of the patient to participate in the study

Exclusion Criteria

  • unregulated hypertension
  • atherosclerosis
  • local blood supply disorders
  • bladder and urinary tract diseases
  • consuming more than 4 cups of coffee or more than 2 alcoholic beverages per day
  • contraindications to the use of whole body cryotherapy
  • participation in other forms of physical activity during the study
  • no consent to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials